Moselle Drugs And Cosmetics Profile
Key Indicators
- Authorised Capital ₹ 2.10 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.87 Cr
as on 12-12-2024
- Company Age 5 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.50 Cr
as on 12-12-2024
- Revenue %
(FY 2023)
- Profit -34.56%
(FY 2023)
- Ebitda -133.53%
(FY 2023)
- Net Worth -19.30%
(FY 2023)
- Total Assets 45.18%
(FY 2023)
About Moselle Drugs And Cosmetics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.10 Cr and a paid-up capital of Rs 1.87 Cr.
The company currently has active open charges totaling ₹2.50 Cr.
Pudugrammam Vaidyanathan, Reji Joy, Sham Singla, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24290HR2019PLC077772
- Company No.
077772
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
10 Jan 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Panchkula, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Moselle Drugs And Cosmetics?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pudugrammam Vaidyanathan  | Director | 10-Jan-2019 | Current |
| Ganapathy Iyer | Director | 10-Jan-2019 | Current |
| Reji Joy | Director | 10-Jan-2019 | Current |
| Sham Singla | Director | 10-Jan-2019 | Current |
| Gurmeet Narula | Director | 10-Jan-2019 | Current |
| Peter Parriathcherry | Director | 10-Jan-2019 | Current |
Financial Performance of Moselle Drugs And Cosmetics.
Moselle Drugs And Cosmetics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 34.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Moselle Drugs And Cosmetics?
In 2023, Moselle Drugs And Cosmetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
R-Vision Eye Hospital Private LimitedActive 5 years 10 monthsPudugrammam Vaidyanathan is a mutual person
Rhine Biogenics Private LimitedActive 21 years 2 monthsPudugrammam Vaidyanathan, Reji Joy and 1 more are mutual person
Mdc Pharmaceuticals LimitedActive 30 years 5 monthsSham Singla and Gurmeet Narula are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 19 Oct 2022 | ₹2.50 Cr | Open |
How Many Employees Work at Moselle Drugs And Cosmetics?
Unlock and access historical data on people associated with Moselle Drugs And Cosmetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Moselle Drugs And Cosmetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moselle Drugs And Cosmetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
